Titre : Cellules endothéliales

Cellules endothéliales : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cognition
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cellules endothéliales : Questions médicales les plus fréquentes", "headline": "Cellules endothéliales : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cellules endothéliales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-18", "dateModified": "2025-04-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cellules endothéliales" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Cellules épithéliales", "url": "https://questionsmedicales.fr/mesh/D004847", "about": { "@type": "MedicalCondition", "name": "Cellules épithéliales", "code": { "@type": "MedicalCode", "code": "D004847", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Progéniteurs endothéliaux", "alternateName": "Endothelial Progenitor Cells", "url": "https://questionsmedicales.fr/mesh/D066026", "about": { "@type": "MedicalCondition", "name": "Progéniteurs endothéliaux", "code": { "@type": "MedicalCode", "code": "D066026", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.182" } } }, { "@type": "MedicalWebPage", "name": "Cellules endothéliales de la veine ombilicale humaine", "alternateName": "Human Umbilical Vein Endothelial Cells", "url": "https://questionsmedicales.fr/mesh/D061307", "about": { "@type": "MedicalCondition", "name": "Cellules endothéliales de la veine ombilicale humaine", "code": { "@type": "MedicalCode", "code": "D061307", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.682" } } }, { "@type": "MedicalWebPage", "name": "Podosomes", "alternateName": "Podosomes", "url": "https://questionsmedicales.fr/mesh/D000069261", "about": { "@type": "MedicalCondition", "name": "Podosomes", "code": { "@type": "MedicalCode", "code": "D000069261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A11.436.275.841" } } } ], "about": { "@type": "MedicalCondition", "name": "Cellules endothéliales", "alternateName": "Endothelial Cells", "code": { "@type": "MedicalCode", "code": "D042783", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peter Carmeliet", "url": "https://questionsmedicales.fr/author/Peter%20Carmeliet", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be." } }, { "@type": "Person", "name": "Kim D Falkenberg", "url": "https://questionsmedicales.fr/author/Kim%20D%20Falkenberg", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Katerina Rohlenova", "url": "https://questionsmedicales.fr/author/Katerina%20Rohlenova", "affiliation": { "@type": "Organization", "name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium." } }, { "@type": "Person", "name": "Yonglun Luo", "url": "https://questionsmedicales.fr/author/Yonglun%20Luo", "affiliation": { "@type": "Organization", "name": "Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China." } }, { "@type": "Person", "name": "Walter Muranyi", "url": "https://questionsmedicales.fr/author/Walter%20Muranyi", "affiliation": { "@type": "Organization", "name": "Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.", "datePublished": "2022-11-21", "url": "https://questionsmedicales.fr/article/36424289", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.schres.2022.11.004" } }, { "@type": "ScholarlyArticle", "name": "Treatment preferences among adults with normal cognition and cognitive impairment.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36094330", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jgs.18032" } }, { "@type": "ScholarlyArticle", "name": "Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.", "datePublished": "2023-01-09", "url": "https://questionsmedicales.fr/article/36634906", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.neuroscience.2023.01.004" } }, { "@type": "ScholarlyArticle", "name": "Deep Cognitive Gate: Resembling Human Cognition for Saliency Detection.", "datePublished": "2022-08-04", "url": "https://questionsmedicales.fr/article/33755558", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1109/TPAMI.2021.3068277" } }, { "@type": "ScholarlyArticle", "name": "Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial.", "datePublished": "2023-03-04", "url": "https://questionsmedicales.fr/article/36921506", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.archger.2023.104984" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Cellules", "item": "https://questionsmedicales.fr/mesh/D002477" }, { "@type": "ListItem", "position": 3, "name": "Cellules épithéliales", "item": "https://questionsmedicales.fr/mesh/D004847" }, { "@type": "ListItem", "position": 4, "name": "Cellules endothéliales", "item": "https://questionsmedicales.fr/mesh/D042783" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cellules endothéliales - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cellules endothéliales", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cellules endothéliales", "description": "Comment diagnostiquer une dysfonction endothéliale ?\nQuels examens pour évaluer les cellules endothéliales ?\nQuels marqueurs biologiques indiquent une inflammation endothéliale ?\nComment évaluer la perméabilité endothéliale ?\nQuels tests pour détecter des lésions endothéliales ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cellules endothéliales", "description": "Quels symptômes indiquent une dysfonction endothéliale ?\nComment reconnaître une inflammation endothéliale ?\nQuels signes cliniques d'athérosclérose ?\nQuels symptômes d'une thrombose veineuse ?\nComment se manifeste une ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cellules endothéliales", "description": "Comment prévenir la dysfonction endothéliale ?\nQuelles habitudes pour réduire l'inflammation ?\nComment prévenir l'athérosclérose ?\nQuelles mesures pour éviter la thrombose ?\nComment réduire le risque d'ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cellules endothéliales", "description": "Quels traitements pour la dysfonction endothéliale ?\nComment traiter l'inflammation endothéliale ?\nQuelles interventions pour l'athérosclérose ?\nQuels médicaments pour prévenir la thrombose ?\nComment gérer l'ischémie chronique ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cellules endothéliales", "description": "Quelles complications de la dysfonction endothéliale ?\nQuels risques liés à l'inflammation endothéliale ?\nQuelles complications de l'athérosclérose ?\nQuels dangers d'une thrombose veineuse ?\nQuelles complications de l'ischémie ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cellules endothéliales", "description": "Quels facteurs de risque pour la dysfonction endothéliale ?\nComment le stress influence-t-il l'endothélium ?\nQuels rôles du cholestérol dans la santé endothéliale ?\nComment l'alimentation affecte-t-elle l'endothélium ?\nQuels impacts de l'inactivité physique sur l'endothélium ?", "url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Cognition&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction endothéliale ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests comme l'échographie Doppler et les marqueurs sanguins peuvent être utilisés." } }, { "@type": "Question", "name": "Quels examens pour évaluer les cellules endothéliales ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les biopsies tissulaires et les analyses histologiques sont couramment pratiquées." } }, { "@type": "Question", "name": "Quels marqueurs biologiques indiquent une inflammation endothéliale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des marqueurs comme la protéine C-réactive et les cytokines peuvent être mesurés." } }, { "@type": "Question", "name": "Comment évaluer la perméabilité endothéliale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de perméabilité utilisant des colorants ou des marqueurs radioactifs sont effectués." } }, { "@type": "Question", "name": "Quels tests pour détecter des lésions endothéliales ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'angiographie et l'imagerie par résonance magnétique peuvent révéler des lésions." } }, { "@type": "Question", "name": "Quels symptômes indiquent une dysfonction endothéliale ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs thoraciques, des troubles circulatoires et des œdèmes peuvent survenir." } }, { "@type": "Question", "name": "Comment reconnaître une inflammation endothéliale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur et gonflement au site affecté sont des signes d'inflammation." } }, { "@type": "Question", "name": "Quels signes cliniques d'athérosclérose ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs dans la poitrine, fatigue et essoufflement peuvent indiquer une athérosclérose." } }, { "@type": "Question", "name": "Quels symptômes d'une thrombose veineuse ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Gonflement, douleur et rougeur dans la zone touchée sont des symptômes courants." } }, { "@type": "Question", "name": "Comment se manifeste une ischémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "L'ischémie se manifeste par des douleurs, des engourdissements et une faiblesse musculaire." } }, { "@type": "Question", "name": "Comment prévenir la dysfonction endothéliale ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel." } }, { "@type": "Question", "name": "Quelles habitudes pour réduire l'inflammation ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabac, réduire le stress et consommer des aliments anti-inflammatoires aide." } }, { "@type": "Question", "name": "Comment prévenir l'athérosclérose ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Contrôler la pression artérielle, le cholestérol et pratiquer une activité physique régulière." } }, { "@type": "Question", "name": "Quelles mesures pour éviter la thrombose ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Rester actif, s'hydrater et éviter de rester immobile longtemps sont des mesures préventives." } }, { "@type": "Question", "name": "Comment réduire le risque d'ischémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Gérer le diabète, contrôler le poids et éviter les aliments riches en graisses saturées." } }, { "@type": "Question", "name": "Quels traitements pour la dysfonction endothéliale ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments comme les statines et des changements de mode de vie sont recommandés." } }, { "@type": "Question", "name": "Comment traiter l'inflammation endothéliale ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des anti-inflammatoires et des corticostéroïdes peuvent être prescrits selon la gravité." } }, { "@type": "Question", "name": "Quelles interventions pour l'athérosclérose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des procédures comme l'angioplastie ou le pontage peuvent être nécessaires." } }, { "@type": "Question", "name": "Quels médicaments pour prévenir la thrombose ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les anticoagulants et les antiplaquettaires sont souvent utilisés pour prévenir la thrombose." } }, { "@type": "Question", "name": "Comment gérer l'ischémie chronique ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des traitements médicaux, des exercices et parfois une chirurgie sont envisagés." } }, { "@type": "Question", "name": "Quelles complications de la dysfonction endothéliale ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des maladies cardiovasculaires, des AVC et des troubles circulatoires." } }, { "@type": "Question", "name": "Quels risques liés à l'inflammation endothéliale ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "L'inflammation peut provoquer des thromboses, des embolies et des maladies auto-immunes." } }, { "@type": "Question", "name": "Quelles complications de l'athérosclérose ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut mener à des crises cardiaques, des AVC et des douleurs angineuses." } }, { "@type": "Question", "name": "Quels dangers d'une thrombose veineuse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une thrombose peut provoquer une embolie pulmonaire, mettant en danger la vie." } }, { "@type": "Question", "name": "Quelles complications de l'ischémie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'ischémie peut entraîner des lésions tissulaires, des gangrènes et des amputations." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la dysfonction endothéliale ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'hypertension, le diabète, le tabagisme et l'obésité augmentent le risque." } }, { "@type": "Question", "name": "Comment le stress influence-t-il l'endothélium ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress chronique peut aggraver l'inflammation et la dysfonction endothéliale." } }, { "@type": "Question", "name": "Quels rôles du cholestérol dans la santé endothéliale ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un taux élevé de cholestérol LDL est un facteur de risque majeur pour les maladies vasculaires." } }, { "@type": "Question", "name": "Comment l'alimentation affecte-t-elle l'endothélium ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en graisses saturées et en sucres peut nuire à la fonction endothéliale." } }, { "@type": "Question", "name": "Quels impacts de l'inactivité physique sur l'endothélium ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le manque d'exercice physique contribue à la dysfonction endothéliale et aux maladies cardiovasculaires." } } ] } ] }

Sources (10000 au total)

Computerized cognitive and social cognition training in schizophrenia for impulsive aggression.

Schizophrenia is associated with an elevated risk for impulsive aggression for which there are few psychosocial treatment options. Neurocognitive and social cognitive deficits have been associated wit... The two-center study randomized 130 participants to receive 36 sessions of either a combination of cognitive remediation and social cognition treatment or cognitive remediation plus a computer-based c... Study participants were mostly male (84.5 %), had a mean age 34.9 years, and 11.5 years of education. Both Cognitive Remediation Training (CRT) plus Social Cognition Training (SCT) and CRT plus contro... CRT proved to be an effective non-pharmacological treatment in reducing impulsive aggression in schizophrenia inpatient participants with a history of aggressive episodes. The addition of social cogni...

Treatment preferences among adults with normal cognition and cognitive impairment.

Although patient participation in treatment decisions is important for preference-concordant care delivery, it is largely unknown how cognitive impairment influences treatment preferences. We investig... Data from the 2018 Health and Retirement Study were used. The sample included 1291 self-respondents (201 respondents with cognitive impairment, and 1090 with normal cognition). We examined treatment p... Respondents with cognitive impairment were more likely to report that they were unsure about treatment options across both clinical scenarios compared to those with normal cognition. For the limited t... Compared to those with normal cognition, cognitive impairment was associated with greater uncertainty about treatment preferences and higher rates of aggressive care preferences among those who specif...

Brain Functional Alterations and Association with Cognition in People with Preclinical Subjective Cognitive Decline and Objective Subtle Cognitive Difficulties.

Subjective cognitive decline (SCD) and objective subtle cognitive difficulties (Obj-SCD) are considered the initial stages of aberrant cognition prior to mild cognitive impairment (MCI) due to Alzheim...

Effects of cognitive stimulation program on cognition and mood in older adults, stratified by cognitive levels: A randomized controlled trial.

Cognitive stimulation (CS) is defined as activities that involve cognitive processing, usually conducted in a social context and often in a group. This study aims to evaluate the effects of a personal... The randomized controlled single-blind trial involving 337 participants (235 women and 102 men) ≥ 65 years of age in a Primary Care centre classified participants into 4 groups: 101 for the no deterio... The intervention showed a tendency of improvement on global cognition and different cognitive functions for groups with no deterioration or level deterioration. The group with moderate deterioration i... The findings demonstrated benefits in global cognition, different cognitive functions, semantic fluency, IADLs and anxiety. The most benefits are given in the intermediate groups, SCI, and LD. Moreove...

Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old-old.

The Montreal Cognitive Assessment (MoCA) was developed as a screening tool for mild cognitive impairment (MCI). Given the need for a rapid screening test in settings such as primary care, we compare t... Cross-sectional study involving community-dwelling 'old' (65 to 79 years old) and 'old-old' (≥ 80 years old) without dementia. Cognitive impairment was defined by MoCA score 17 to 22. Validation was d... Of the 183 participants (mean age 72.1 ± 5.2 years),15.8% (n = 29) were classified as cognitively impaired. The overall ROC curve had an AUC of 0.82 (95% CI 0.75-0.90, P < 0.01) with an optimal cut-of... The three-item RCS is quick and easy to administer. Although RCS met the criterion for good validity against MoCA in predicting cognitive impairment, its utility as a first-line screening tool needs t...

The Effect of Hearing Loss on Cognitive Function in Subjective Cognitive Decline.

Subjective cognitive decline (SCD) is a self-reported cognitive decline without objective cognitive impairment. The relationship between audiometric hearing loss (HL) and cognitive function has not be... This is a cross-sectional study that used the baseline data of a multicenter cohort study that monitors clinical progression from SCD to dementia. Individuals aged ≥60 years who reported cognitive dec... Of a total of 120 participants, one hundred and two had NH (n = 57) or bilateral HL (n = 45). There were no group differences in the demographic and clinical data except the age. The biomarkers, globa... In SCD, HL exerted an adverse effect on cognitive function, primarily frontal executive function tested in the Stroop task. HL was also related to gray matter volume reductions in brain subregions, al...

Physical and cognitive function to explain the quality of life among older adults with cognitive impairment: exploring cognitive function as a mediator.

Physical and cognitive function are both indicators of aging, characterized by a loss of adaptive response to life challenges and functional limitations, subsequently affecting their quality of life. ... The study participants were 79 older adults recruited from community centers in four urban districts of Korea. All participants completed a self-reported questionnaire for demographic characteristics ... The mean age of participants was 77.46 years old with an elementary or lower education level (53.2%). The mean score of cognitive function was 16.39 (SD = 6.5). Physical function (grip strength, balan... In conclusion, physical and cognitive function were significant predictors of QOL in older adults with cognitive impairment. Specifically, balance has significant indirect effects on the physical comp...

Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.

Both Alzheimer's disease (AD) genetic risk factors and indices of cognitive reserve (CR) influence risk of cognitive decline, but it remains unclear whether they interact. This study examined whether ... Analyses used data from the Preclinical AD Consortium, including harmonized data from 5 longitudinal cohort studies. Participants were cognitively normal at baseline (M baseline age = 64 years, 59% fe... In mixed-effects models, higher CR index scores were associated with better baseline cognitive performance for all cognitive outcomes. APOE-ε4 genotype and AD-PRS that included the APOE region (AD-PRS... These results suggest that APOE-ε4 and non-APOE-ε4 AD polygenic risk are independently associated with global cognitive and executive function declines among individuals with normal cognition at basel...